SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

eye-vision

How to Prevent Macular Degeneration: Diet and Lifestyle

AMD risk and progression can be reduced by quitting smoking, eating a diet rich in leafy greens and fish, controlling blood pressure, and wearing UV-protective sunglasses. For those with intermediate or advanced AMD in one eye, the AREDS2 vitamin formulation (lutein, zeaxanthin, vitamins C and E, zinc, and copper) reduced the risk of advancing to late-stage disease by about 25% in a large clinical trial.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

What is macular degeneration, and who gets it?

The macula is the central part of the retina responsible for sharp, detailed central vision — the vision used for reading, recognizing faces, and seeing fine detail. AMD occurs when the cells and support tissue of the macula gradually break down.

There are two main forms: - Dry AMD — the more common form, characterized by the accumulation of small protein deposits called drusen beneath the retina. Most people with AMD have the dry form. It progresses slowly over years. - Wet AMD — less common but more rapidly damaging. Abnormal blood vessels grow under the retina and leak fluid or blood, causing rapid central vision distortion and loss. Wet AMD can develop from dry AMD.

AMD is the leading cause of central vision loss in people over 50 in developed countries 12. Genetics and age are the strongest non-modifiable risk factors, but several lifestyle factors are meaningfully modifiable.

What are the risk factors for AMD?

Several factors influence who develops AMD and how quickly it progresses 12:

Non-modifiable: - Age — risk rises sharply after age 60 and more so after 75 - Genetics — family history substantially increases risk; several genetic variants have been identified - Race — AMD is more common in white-skinned individuals compared to Black or Hispanic populations

Modifiable: - Smoking — the single most important modifiable risk factor; smokers have a significantly higher risk of developing AMD and of progressing to late-stage disease 2 - Cardiovascular disease and hypertension — associated with AMD risk, likely through effects on blood supply to the retina - Obesity - Prolonged UV light exposure — wearing protective eyewear outdoors reduces this exposure - Diet — diets low in antioxidants, leafy greens, and omega-3 fatty acids may be associated with higher risk

What do the AREDS2 vitamins do, and who should take them?

The Age-Related Eye Disease Study 2 (AREDS2) was a large, randomized clinical trial that tested a specific combination of vitamins and minerals for their ability to slow AMD progression. The AREDS2 formula contains: - Vitamin C (500 mg) - Vitamin E (400 IU) - Lutein (10 mg) - Zeaxanthin (2 mg) - Zinc (80 mg) - Copper (2 mg, to prevent zinc-induced copper deficiency)

In the trial, this formulation reduced the risk of progression to advanced AMD by approximately 25% over five years in people with intermediate AMD or advanced AMD in one eye 3. The AREDS2 formula replaced beta-carotene in the original AREDS formula because beta-carotene increased lung cancer risk in smokers.

This formulation is not for people with no or early AMD — the evidence for benefit applies specifically to people with intermediate AMD (large drusen in one or both eyes) or advanced AMD in one eye 13. An ophthalmologist determines AMD stage and advises whether supplementation is indicated. Over-the-counter 'eye vitamins' marketed to the general public vary in composition; confirm the formulation matches the AREDS2 formula.

What lifestyle changes help prevent or slow AMD?

Stop smoking or do not start — this is the single most impactful modifiable action. Smoking cessation reduces AMD progression risk regardless of how long someone has smoked 2.

Eat a diet rich in lutein and zeaxanthin — these carotenoids are found in high concentrations in the macula and are obtained primarily through diet. Dark leafy greens (kale, spinach, collard greens), eggs, and orange and yellow vegetables are the richest sources. The AREDS2 trial supplemented these nutrients because dietary intake is often insufficient 3.

Include fatty fish in your diet — omega-3 fatty acids (DHA and EPA), found in fish like salmon, mackerel, and sardines, are associated with lower AMD risk in observational data 2.

Protect your eyes from UV light — wear sunglasses that block 99–100% of UVA and UVB rays when outdoors. A broad-brimmed hat adds additional protection.

Manage blood pressure and cardiovascular risk — hypertension management is associated with lower AMD progression risk 2. A primary-care clinician can help with this.

Maintain a healthy weight — obesity is an independent risk factor for AMD progression.

Exercise regularly — regular physical activity supports cardiovascular health, which in turn supports retinal blood flow.

How does an ophthalmologist monitor AMD?

AMD is diagnosed through a dilated eye exam, which allows the ophthalmologist to see the macula directly and identify drusen, changes in the retinal pigment, or evidence of abnormal blood vessel growth. Additional imaging — optical coherence tomography (OCT) — provides highly detailed cross-sectional images of the retina and is the standard tool for monitoring AMD over time 1.

At home, people with AMD are often given an Amsler grid — a simple checkerboard pattern with a central dot. If straight lines appear wavy, bent, or if a gap appears in the grid, this may signal progression to wet AMD and warrants a prompt call to an ophthalmologist.

Wet AMD is treated with injections of anti-VEGF medications into the eye — medications that block the growth of abnormal blood vessels. These injections are effective at stopping or reversing some vision loss in wet AMD when started promptly 1.

Should everyone take eye vitamins as they age?

No. The evidence supports AREDS2 supplements specifically for people with intermediate or advanced AMD — not as a general prevention strategy for the whole population 13. Taking them without appropriate AMD staging is not supported by evidence and adds unnecessary cost.

For people without AMD, the best evidence supports a healthy diet, not smoking, and regular dilated eye exams to detect AMD early if it develops. An ophthalmologist can advise after examining your eyes.

Common questions

Does AMD always lead to blindness?

AMD affects central vision, not peripheral vision, so complete blindness from AMD alone is uncommon. However, advanced AMD can cause significant central vision loss that severely affects reading, driving, and face recognition. Early detection and appropriate treatment (particularly for wet AMD) meaningfully reduces the risk of severe vision loss.

At what age should I start worrying about macular degeneration?

AMD typically becomes clinically apparent after age 50, with risk rising steeply after 60. Regular dilated eye exams beginning in your 40s or 50s allow an ophthalmologist to establish a baseline and monitor for early changes. If you have a family history of AMD, mention this to your eye doctor.

Can the AREDS2 vitamins help someone with early AMD?

The evidence from the AREDS2 trial demonstrated benefit for intermediate and advanced AMD, not early AMD. The distinction between early and intermediate AMD is made by an ophthalmologist based on drusen size and number — not something that can be self-assessed.

Does smoking only matter if I have smoked for many years?

No — smoking is associated with AMD risk even in people who are not long-term heavy smokers, and the risk declines after quitting. Stopping smoking at any point reduces your AMD risk compared to continuing to smoke.

Is there a genetic test for AMD risk?

Genetic testing for AMD risk variants is commercially available, but it is not part of standard clinical care. Family history is a practical and meaningful proxy for genetic risk. An ophthalmologist can advise whether genetic testing would change your monitoring plan.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

When to contact your ophthalmologist promptly

  • Sudden distortion or waviness of straight lines (use your Amsler grid daily if you have AMD)
  • New central blank spot or shadow in your vision
  • Sudden decrease in central vision

If you experience sudden central vision distortion or loss, contact your ophthalmologist the same day. Wet AMD treated early has better outcomes than AMD treated after significant vision loss.

This article provides general information about macular degeneration prevention and is not a substitute for a dilated eye examination or clinical advice. Gale can help you find and prepare for an appointment with an ophthalmologist.

References

  1. 1.Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS (2020). Age-Related Macular Degeneration Preferred Practice Pattern. Ophthalmology. doi:10.1016/j.ophtha.2019.09.024AMD classification (dry vs wet); AREDS2 supplementation for intermediate/advanced AMD; anti-VEGF treatment for wet AMD; monitoring with OCT and Amsler grid; risk factors including smoking; AMD as leading cause of central vision loss over 50
  2. 2.National Eye Institute (2023). Age-Related Macular Degeneration (AMD). National Eye Institute (NEI/NIH). linkAMD as leading cause of central vision loss over 50; modifiable risk factors including smoking, diet (omega-3s, leafy greens), cardiovascular health, UV protection; smoking cessation as primary prevention
  3. 3.Age-Related Eye Disease Study 2 Research Group (2013). Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial. JAMA. doi:10.1001/jama.2013.4997AREDS2 formula (lutein/zeaxanthin replacing beta-carotene) reduced risk of progression to advanced AMD by approximately 25% over 5 years in people with intermediate or advanced AMD; beta-carotene substitution reduced lung-cancer risk for smokers; dietary supplementation not indicated for early AMD

3 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.